• Text size      
  • Send this article to a friend
  • Print this article

Reneuron tests stem cell stroke treatment

RENEURON, a stem cell therapy specialist, has started work on the latest study of a new treatment for stroke damage.

The treatment involves injecting up to 20 million stem cells into patients' brains. It was tested on patients at Glasgow's ­Southern General Hospital in 2012.

The Surrey-based company said it would work at 10 sites across the UK, including the Southern General, on a Phase II efficacy study of the ReN001 treatment involving 41 patients.

The treatment is designed to deliver a meaningful improvement in upper limb function in disabled stroke patients.

In May, the company said data from a long-term follow- up involving 11 patients included in a Phase I safety study of ReN001 at the Glasgow hospital observed sustained reductions in neurological impairment and spasticity in most patients. No cell-related or immunological adverse events were reported .

Yesterday, Reneuron said it has also started a Phase I safety study at Ninewells Hospital in Dundee of its ReN009 therapy for people with lower limb ischaemia. It will involve nine patients.

Reneuron says the disease is common in patients with diabetes and can lead to amputation of the limb.

Contextual targeting label: 
Health

Commenting & Moderation

We moderate all comments on HeraldScotland on either a pre-moderated or post-moderated basis.
If you're a relatively new user then your comments will be reviewed before publication and if we know you well and trust you then your comments will be subject to moderation only if other users or the moderators believe you've broken the rules

Moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours. Please be patient if your posts are not approved instantly.

258881